157 related articles for article (PubMed ID: 25962960)
1. Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer.
Zhang GM; Wan FN; Qin XJ; Cao DL; Zhang HL; Zhu Y; Dai B; Shi GH; Ye DW
Oncotarget; 2015 Jul; 6(21):18460-8. PubMed ID: 25962960
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
3. TREK-1 is a novel molecular target in prostate cancer.
Voloshyna I; Besana A; Castillo M; Matos T; Weinstein IB; Mansukhani M; Robinson RB; Cordon-Cardo C; Feinmark SJ
Cancer Res; 2008 Feb; 68(4):1197-203. PubMed ID: 18281496
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.
Huang Y; Liu X; Wang YH; Yeh SD; Chen CL; Nelson RA; Chu P; Wilson T; Yen Y
Urol Oncol; 2014 Jan; 32(1):51.e9-19. PubMed ID: 24360663
[TBL] [Abstract][Full Text] [Related]
5. Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer.
Innamaa A; Jackson L; Asher V; van Schalkwyk G; Warren A; Keightley A; Hay D; Bali A; Sowter H; Khan R
Clin Transl Oncol; 2013 Nov; 15(11):910-8. PubMed ID: 23479219
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
7. Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice.
Aller MI; Wisden W
Neuroscience; 2008 Feb; 151(4):1154-72. PubMed ID: 18222039
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
9. PSCA promotes prostate cancer proliferation and cell-cycle progression by up-regulating c-Myc.
Li E; Liu L; Li F; Luo L; Zhao S; Wang J; Kang R; Luo J; Zhao Z
Prostate; 2017 Dec; 77(16):1563-1572. PubMed ID: 28971496
[TBL] [Abstract][Full Text] [Related]
10. The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle.
Xian Tao Li ; Dyachenko V; Zuzarte M; Putzke C; Preisig-Müller R; Isenberg G; Daut J
Cardiovasc Res; 2006 Jan; 69(1):86-97. PubMed ID: 16248991
[TBL] [Abstract][Full Text] [Related]
11. Cullin-1 promotes cell proliferation via cell cycle regulation and is a novel in prostate cancer.
Jiang H; He D; Xu H; Liu J; Qu L; Tong S
Int J Clin Exp Pathol; 2015; 8(2):1575-83. PubMed ID: 25973042
[TBL] [Abstract][Full Text] [Related]
12. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract][Full Text] [Related]
13. Over-expressed human TREK-1 inhibits CHO cell proliferation via inhibiting PKA and p38 MAPK pathways and subsequently inducing G1 arrest.
Zhang M; Yin HJ; Wang WP; Li J; Wang XL
Acta Pharmacol Sin; 2016 Sep; 37(9):1190-8. PubMed ID: 27397543
[TBL] [Abstract][Full Text] [Related]
14. Expression of the mechanosensitive 2PK+ channel TREK-1 in human osteoblasts.
Hughes S; Magnay J; Foreman M; Publicover SJ; Dobson JP; El Haj AJ
J Cell Physiol; 2006 Mar; 206(3):738-48. PubMed ID: 16250016
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis.
Sun H; Luo L; Lal B; Ma X; Chen L; Hann CL; Fulton AM; Leahy DJ; Laterra J; Li M
Nat Commun; 2016 Feb; 7():10339. PubMed ID: 26842342
[TBL] [Abstract][Full Text] [Related]
16. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
17. Both TASK-3 and TREK-1 two-pore loop K channels are expressed in H295R cells and modulate their membrane potential and aldosterone secretion.
Brenner T; O'Shaughnessy KM
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1480-6. PubMed ID: 18854423
[TBL] [Abstract][Full Text] [Related]
18. A splice variant of the two-pore domain potassium channel TREK-1 with only one pore domain reduces the surface expression of full-length TREK-1 channels.
Rinné S; Renigunta V; Schlichthörl G; Zuzarte M; Bittner S; Meuth SG; Decher N; Daut J; Preisig-Müller R
Pflugers Arch; 2014 Aug; 466(8):1559-70. PubMed ID: 24196565
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer.
Sauter DR; Sørensen CE; Rapedius M; Brüggemann A; Novak I
Biochim Biophys Acta; 2016 Oct; 1862(10):1994-2003. PubMed ID: 27443495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
